WVE-210201 (Suvodirsen)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WVE-210201 (Suvodirsen), covering 2021-05-20 to 2021-05-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy [Phase 2, Phase 3]